电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Ribokinase 抗体 (AA 1-322)

The 小鼠 多克隆 anti-Ribokinase antibody is suitable to detect Ribokinase in samples from 人. It has been validated for WB.
产品编号 ABIN528509
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Ribokinase 抗体 (AA 1-322) (ABIN528509)

抗原

See all Ribokinase (RBKS) 抗体
Ribokinase (RBKS)

适用

  • 21
  • 12
  • 1

宿主

  • 30
  • 3
小鼠

克隆类型

  • 31
  • 2
多克隆

标记

  • 13
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Ribokinase antibody is un-conjugated

应用范围

  • 21
  • 19
  • 9
  • 3
  • 1
Western Blotting (WB)
  • 抗原表位

    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    AA 1-322

    原理

    Mouse polyclonal antibody raised against a full-length human RBKS protein.

    序列

    MAASGEPQRQ WQEEVAAVVV VGSCMTDLVS LTSRLPKTGE TIHGHKFFIG FGGKGANQCV QAARLGAMTS MVCKVGKDSF GNDYIENLKQ NDISTEFTYQ TKDAATGTAS IIVNNEGQNI IVIVAGANLL LNTEDLRAAA NVISRAKVMV CQLEITPATS LEALTMARRS GVKTLFNPAP AIADLDPQFY TLSDVFCCNE SEAEILTGLT VGSAADAGEA ALVLLKRGCQ VVIITLGAEG CVVLSQTEPE PKHIPTEKVK AVDTTGAGDS FVGALAFYLA YYPNLSLEDM LNRSNFIAAV SVQAAGTQSS YPYKKDLPLT LF

    交叉反应

    产品特性

    Antibody reactive against mammalian transfected lysate.

    免疫原

    RBKS (NP_071411.1, 1 a.a. ~ 322 a.a) full-length human protein.
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 缓冲液

    In 1x PBS, pH 7.4

    注意事项

    Aliquot to avoid repeated freezing and thawing.

    储存条件

    -20 °C

    储存方法

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • 抗原

    Ribokinase (RBKS)

    别名

    RBKS

    背景

    Full Gene Name: ribokinase
    Synonyms: DKFZp686G13268,RBSK

    基因ID

    64080

    NCBI登录号

    NM_022128
You are here: